Newsletter | May 27, 2025

05.27.25 -- Fill/Finish Services, Technologies, And Innovations

SPONSOR

Join Outsourced Pharma Live on June 11th at 2pm ET for a virtual panel discussion on the specific challenges of biologics development that must drive CDMOs to embrace more flexible approaches. Registration is free thanks to the support of Curia.

Combination Products

With expertise in injectables, respiratory combination products, and ocular products, Kymanox provides turnkey services to bring your product from concept to commercialization.

Request Information

Kymanox Corporation

Comprehensive Biologic Development And Manufacturing Services

Our capabilities include filling vials (liquid or lyophilized), pre-filled syringes (PFS), and cartridge product types, supporting batch sizes of 1,000 to 100,000 vials and up to 120 batches annually.

Request Information

Mycenax

Regulatory Confidence, Manufacturing Excellence

Jubilant HollisterStier is your partner for the contract manufacturing of sterile injectables, lyophilized products, and ophthalmic solutions. Reliability at every stage of the product lifecycle.

Request Information

Jubilant HollisterStier

Drug Product And Finished Goods Manufacturing

Executive Director of Technology and Business Development for Drug Product and Finished Goods, Henrik Herrmann, shares an update on the current and future state of FDB’s capabilities.

Request Information

FUJIFILM Diosynth Biotechnologies

Support At Every Stage Of Drug Development And Manufacturing

Learn about our new facility expansions, enhanced filling capacity, and advanced packaging capabilities that are designed to support and elevate your drug development projects.

Request Information

INCOG BioPharma Services

Benefits Of A Central European CDMO For Drug Product Fill/Finish Services

Backed by years of dedication to customer-focused solutions, we’re proud to introduce our specialists to the global biopharma community and share insights that drive innovation forward.

Request Information

Mabion

Biologics Drug Product Commercial Manufacturing

Discover how Lonza Biologics’ end-to-end drug product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities.

Request Information

Lonza

Fill/Finish Solutions For Sterile Injectables

Senior Key Account Manager, Dr. Jürgen Lübbehusen highlights IDT Biologika´s overall fill/finish capabilities and capacities, with a focus on our ability to help meet your complex needs.

Request Information

IDT Biologika

Capacity With Proven Capability

Join Darren Hieber as he presents an overview of Lifecore Biomedical’s newly expanded capabilities, designed to meet the growing demands of innovative therapeutics.

Request Information

Lifecore Biomedical